1.         The International Classification of Headache Disorders.  Published on behalf of the International Headache Society. Cephalalgia 2004;24 (Suppl 1):1-160, In Press.

2.         Lipton RB, Stewart WF. Migraine in the United States: epidemiology and health care utilization. Neurology 1993;(Suppl. 3) 43:6-10.

3.         Stewart WF, Lipton RB, Celentano DD, et.al. Prevalence of migraine headache in the United States. JAMA 1992;267:64-9.

4.         Rasmussen BK, Jensen R, Schroll M. Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 1991;44:1147-57.

5.         Sacks OW. Migraine, the Evolution of a Common Disorder. Los Angeles: Univ. California Press; 1970.

6.         Gowers WR. Subjective visual sensations. Trans Ophthalmol Soc UK 1895;15:1.

7.         Troost BT, Newton TH. Occipital lobe arteriovenous malformations:  Clinical and radiologic features in 26 cases with comments on the differentiation from migraine. Arch Ophthalmol 1975;93:250-6.

8.         Blau JN. Migraine prodromes separated from the aura: complete migraine. Br Med J 1980;281:658-60.

9.         Silberstein SD, Lipton RB. Overview of diagnosis and treatment of migraine. Neurology 1994;(Suppl. 7) 44:6-16.

10.       Lipton RB, Stewart W, Celentano DD, et.al. Undiagnosed migraine: a comparison of symptom-based and self- reported physician diagnosis. Arch Intern Med 1992;156:1-6.

11.       Stewart WF, Schecter A, Lipton RB. Migraine heterogenity: disability, pain intensity, attack frequency, and duration. Neurology 1994;(Suppl. 4) 44:24-39.

12.       Amery WK, Van Neueten JM, Wauquier A. The Pharmocological Basis of Migraine Therapy. London: Pitman; 1984.

13.       Rose CF. Progress in Migraine Research 2. London: Pitman; 1984.

14.       Raskin NH. Headache. 2 ed. New York: Churchill Livingstone; 1988.

15.       Dalessio DJ. Wolff's Headache and Other Head Pain. 6 ed. New York: Oxford University Press; 1993.

16.       Goadsby PJ, Lipton RB, Ferrari MD. Migraine-Current Understanding and Treatment. N Engl J Med 2002;346(4):257-70.

17.       Goadsby PJ. Pathophysiology of headache. In: Silberstein SD, Lipton RB, Dalessio DJ, eds. Wolff's headache and other pain. 7 ed. Oxford, England: Oxford University Press; 2001:57-72.

18.       Ophoff RA, Terwindt GM, Vergouwe MN, et.al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996;87:543-52.

19.       Terwindt GM, Ophoff RA, van Eijk R, et.al. Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology 2001;56:1028-32.

20.       Kors E, Haan J, Ferrari M. Migraine Genetics. Curr Headache Rep 2003;2:72-7.

21.       Russell MB, Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ 1995;311:541-4.

22.       Wessman M, Kallela M, Kaunisto MA, et.al. A susceptibility locus for migraine with aura, on chromosome. Am J Hum Genet 2002;70:652-62.

23.       Welch KMA. Relationship of stroke and migraine. Neurology 1994;(Suppl. 7) 44:33-6.

24.       Olesen J, Larsen B, Lautitzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981;9:344-52.

25.       Skyhoj-Olesen TS, Friberg L, Lassen NA. Ischemia may be the primary cause of the neurologic deficits in classic migraine. Arch Neurol 1987;44:156-61.

26.       May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cere Blood Flow Metab 1999;19:115-27.

27.       Weiller C, May A, Limmroth V, et.al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995;1:658-60.

28.       Bahra A, Matharu MS, Buchel C, Frackowiak RSJ, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet 2001;357:1016-7.

29.       Sicuteri F. Vasoneuroactive substances in migraine. Headache 1966;6:109.

30.       Lance JW, Anthony M, Gonski A. Serotonin, the carotid body, and cranial vessels in migraine. Arch Neurol 1967;16:553.

31.       Curran AC, Hinterberger H, Lance JW. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain 1966;88:997.

32.       Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984;16:157-68.

33.       Raskin NH. Chemical headaches. Ann Rev Med 1981;32:63-71.

34.       Wolff HG. Headache and Other Head Pain. New York: Oxford Univ Press; 1963.

35.       O'Brien M. Cerebral blood changes in migraine. Headache 1971;10:139.

36.       Simard D, Pauson OB. Cerebral vasomotor paralysis during migraine attack. Arch Neurol 1973;29:207.

37.       Brewerton TD, Murphy DL, Mueller EA, et.al. Induction of migraine-like headaches by the serotonin agonist m- chlorophenylpiperazine. Clin Pharmacol Ther 1988;43:605-9.

38.       Gordon ML, Lipton RB, Brown SL, et.al. Headache and cortical responses to m-chlorophenylpiperazine are highly correlated. Cephalalgia 1993;13:400-5.

39.       Friedman AP, Merritt HH. Headache:  Diagnosis and Treatment. Philadelphia: Davis; 1959.

40.       Callahan N. The migraine syndrome in pregnancy. Neurology 1968;18:197.

41.       Shafey S, Scheinberg P. Neurological syndromes in patients receiving synthetic steroids. Neurology 1966;16:205.

42.       Phillips BM. Oral contraceptive drugs and migraine. Br Med J 1968;2:99.

43.       Whitty CWM, Hockaday KM, Whitty MM. The effect of oral contraceptives on migraine. Lancet 1966;1:856.

44.       Somerville BW. Estrogen-withdrawal migraine:  I,  Duration or exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology 1975;25:235.

45.       Hanington E, Horn M, Wilkinson M. Further observations on the effects of tyramine. In: Cochrane AL, ed. Background to Migraine, Third Migraine Symposium. London: Heinemann; 1969:113-9.

46.       Haas DC, Pindela GS, Lourie H. Juvenile head trauma syndromes and their relationship to migraine. Arch Neurol 1975;32:727-30.

47.       Paulson GW, Klawans HL. Benign Orgasmic cephalgia. Headache 1974:1-17.

48.       Milner PM. Note on a possible correspondence between the scotomas of migraine and spreading depression of Lea. Electroencephalogy Clin Neurophysiol 1958;10:705.

49.       Lashley KS. Patterns of cerebral integration indicated by scotomas of migraine. Arch Neurol Psych 1941;46:333.

50.       Leao AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944;7:359-90.

51.       Woods RP, Iacoboni M, Mazziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994;331:1689-92.

52.       Sanchez Del Rio M, Bakker D, Wu O, et.al. Perfusion weighted imaging during migraine:  spontaneous visual aura and headache. Cephalalgia 1999;19:701-7.

53.       Cutrer FM, Sorensen AG, Weisskoff RM, et.al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 1998;43:25-31.

54.       Lauritzen M. Pathophysiology of the migraine aura:  the spreading depression theory. Brain 1994;117:199-210.

55.       Hadjikhani N, Sanchez Del Rio M, Wu O, et.al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 2001;98:4687-92.

56.       Olesen J, Friberg L, Olsen TS, et.al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990;28:791-8.

57.       Cao Y, Welch KMA, Aurora S, Vikingstad EM. Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol 1999;56:548-54.

58.       Feindel W, Penfield W, McNaughton F. The tentorial nerves and localization of intracranial pain in man. Neurology 1960;10:555-63.

59.       Arbab MA-R, Wiklund L, Svendgaard NA. Origin and distribution of cerebral vascular    innervation from superior cervical, trigeminal, and spinal ganglia investigated with retrograde and anterograde WGA-HRP tracing in the rat. Neuroscience 1986;19:695-708.

60.       Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990;28:183-7.

61.       Moskowitz MA, Cutrer FM. Sumatriptan:  a receptor-targeted treatment for migraine. Ann Rev Med 1993;44:145-54.

62.       Troost BT. Botulinum Toxin Type A (BoNT-A) in the Management of Headache:  A review of the Literature and Personal Experience. J Headache & Pain 2004:In Press.

63.       Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol 2000;47:614-24.

64.       May A, Buchel C, Turner R, Goadsby PJ. Magnetic resonance angiography in facial and other pain:  neurovascular mechanisms of trigeminal sensation. J Cereb Blood Flow Metab 2001;21:1171-6.

65.       Alverez WC. The migrainous scotoma is studied in 618 persons. Am J Ophthalmol 1960;49:389.

66.       Klee A, Willanger R. Disturbance of visual perception in migraine. Acta Neurol Scand 1966;42:400.

67.       Walsh FB, Hoyt WF. Clinical Neuro-Ophthalmology. 3 ed. Baltimore: Williams & Wilkins; 1969.

68.       Gowers WR. Visual sensations in migraine. In: Gowers WR, ed. Subjective Sensations of Sight and Sound, Abiotrophy and Other Lectures. London: Churchill; 1907:18-41.

69.       Peatfield C, Rose F. Migrainous visual symptoms in a woman without eyes. Arch Neurol 1981;38:466.

70.       Day JW, Raskin NH. Thunderclap headache: symptoms of unruptured aneursym. Lancet 1986;2:1247-8.

71.       Haas DC. Prolonged migraine aura status. Ann Neurol 1982;11:197.

72.       Fisher CM. Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci 1980;7:9.

73.       Troost BT, Mark LE, Maroon JC. Resolution of classic migraine following removal of an occipital lobe arteriovenous malformation. Ann Neurol 1979;5:199-201.

74.       Bartleson JD. Transient and persistent neurological manifestations of migraine. Stroke 1984;15:383-6.

75.       Berg MJ, Williams LS. The transient syndrome of headache with neurologic deficits and CSF lymphocytosis. Neurology 1995;45:1648-54.

76.       Dvorkin GS, Andermann F, Carpenter S, et.al. Classical migraine, intractable epilepsy, and multiple strokes: a syndrome related to mitochondrial encephalomyopathy. In: Andermann F, Lugaresi E, eds. Migraine and epilepsy. Stoneham, Mass.: Butterworths; 1987:203-32.

77.       Fitzsimons R, Wolfenden WH. Migraine coma: menigitic migraine with cerebral edema associated with a new form of autosomal dominant cerebellar ataxia. Brain 1985;108:555-77.

78.       Caplan L. Intracerebral hemorrhage revisited. Neurology 1988;38:624-7.

79.       Levine SR, Joseph R, D'Andrea G, et.al. Migraine and the lupus anticoagulant. Cephalalgia 1987:93-9.

80.       Ormond AW. Two cases of permanent hemianopsia following severe attacks of migraine. Ophthalmol Rev 1913;32:192.

81.       Butler TH. Scotoma in migrainous subjects. Br J Ophthalmol 1933;17:83.

82.       Butler TH. Uncommon symptoms of migraine. Trans Ophthalmol Soc UK 1941;61:205.

83.       Rothrock JF, Walicke P, Swenson MR, et.al. Migrainous stroke. Arch Neurol 1988;45:63-7.

84.       Bougousslavsky J, Regli F, VanMelle G, et.al. Migraine stroke. Neurology 1988;38:223-7.

85.       Tzourio C, Iglesias S, Hubert J-B, et.al. Migraine and risk of ischemic stroke: a case-controlled study. Br Med J 1993;307:289-92.

86.       Hollenhorst RB. Ocular manifestations of migraine:  Report of 4 cases of hemianopsia. Proc Staff Meeting Mayo Clinic 1958;28:686.

87.       Rich WM. Permanent quadrantanopia after migraine. Br Med J 1948;116:592.

88.       Bruyn GW. Complicated migraine. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. New York: American Elsevier; 1968:59-95.

89.       Connor RCR. Complicated migraine:  A study of permanent neurological and visual defects by migraine. Lancet 1962;2:1072.

90.       Caplan L, Chedru F, Lhermitte F, et.al. Transient global amnesia and migraine. Neurol 1981;31:1167.

91.       Selby G, Lance JW. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psych 1960;23:23.

92.       Smyth VOG, Winter AL. The EEG and migraine. Electroenceph Clin Neurophysiol 1964;16:194.

93.       Boudin G, Pepin B, Barbizet J, et.al. Migraine and EEG disturbances. Electroenceph Clin Neurophysiol 1962;14:141.

94.       Hockaday JM, Whitty CWM. Factors determining the electroencephalogram in migraine:  A study of 560 patients according to clinical type of migraine. Brain 1969;92:769.

95.       Friedman MW. Occlusion of central retinal vein in migraine. Arch Ophthalmol 1951;45:678.

96.       Heyck H. Pathogenesis of migraine. In: Friedman AP, ed. Research and Clinical Studies in Headache. New York: Karger; 1969:1-28.

97.       Heyck H. Varieties of hemiplegic migraine. Heachache 1973;14:135.

98.       Alpers BJ, Yaskin HE. Pathogenesis of ophthalmoplegic migraine. Arch Ophthalmol 1951;45:555.

99.       Patterson RH, Goodell H, Dunning HS. Complications of carotid arteriography. Arch Neurol 1964;10:513.

100.     Friedman AP, Finley KH, Graham JR, et.al. Classification of headache. Neurology 1962;12:173.

101.     Whitty CWM. Familial hemiplegic migraine. J Neurol Neurosurg Psych 1953;16:172.

102.     Blau JN, Whitty CWM. Familial hemiplegic migraine. Lancet 1955;2:1115.

103.     Heyck H. Die neurologischen Begleiterscheinungen der Migraine und das Problem des "angiospastischen Herninsults". Nervenarzt 1962;33:193.

104.     Rosenbaum HE. Familial hemiplegic migraine. Neurology 1960;10:164.

105.     Ohta M, Araki S, Kuroiwa Y. Familial occurrence of migraine with hemiplegic syndrome and cerebellar manifestations. Neurology 1967;17:813.

106.     Young GF, Leon-Barth CA, Green J. Familial hemiplegic migraine, retinal degeneration, deafness, and nystagmus. Arch Neurol 1970;23:201.

107.     Dooling EC, Sweeney VP. Migrainous hemiplegia during breast feeding. Am J Obstet Gynecol 1974;118:568.

108.     Straube A, Bandmann O, Buttner U, Schmidt H. A contrast enhanced lesion of the III nerve on MR of a patient with ophthalmoplegic migraine as evidence for a tolosa-Hunt syndrome. Headache 1994;33(8):446-8.

109.     Wong V, Wong WC. Enhancement of oculomotor nerve-A diagnostic criterion for ophthalmoplegic migraine. Pediatr Neurol 1997;17:70-3.

110.     Troost BT. Migraine, Ophthalmoplegic and Retinal. Encycloped  Neurol Sciences 2003:167-8.

111.     Troost BT, Tomsak RL. Ophthalmoplegic Migraine and Retinal Migraine. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. New York: Raven Press Ltd.; 1993:421-6.

112.     Tomsak RL, Masaryk TJ, Bates JH. Magnetic resonance angiography (MRA) of isolated aneurysmal third nerve palsy. J Clin Neuro-ophthalmol 1991;11:16-8.

113.     Woody RC, Blaw ME. Ophthalmoplegic migraine in infancy. Clin Pediatr 1986;25:82-4.

114.     Hallet M, Cogan DG. Episodic unilateral mydriasis in otherwise normal patients. Arch Ophthalmol 1970;84:130.

115.     Edelson RN, Levy DE. Transient benign unilateral pupillary dilatation in young adults. Arch Neurol 1974;31:12.

116.     Sarkies NJC, Sanders MD, Gautier-Smith PC. Episodic unilateral mydriasis and migraine (letter). Am J Ophthalmol 1985;99:217-8.

117.     Durkan GP, Troost BT, Slamovits TL, et.al. Recurrent painless oculomotor palsy in children:  a variant of ophthalmoplegic migraine. Headache 1981;21:58.

118.     Gabianelli EB, Klingele TG, Burde RM. Acute oculomotor nerve palsy in childhood. Is arteriography necessary? J Clin Neuro-ophthalmol 1989;9:33-6.

119.     Walsh JP, O'Doherty DS. A possible explanation of the mechanism of ophthalmoplegic migraine. Neurology 1960;10:1079.

120.     Friedman AP, Harter DH, Merritt HH. Ophthalmoplegic migraine. Arch Neurol 1962;7:320.

121.     Osuntoken O, Osuntoken BO. Ophthalmoplegic migraine and hemoglobinopthy in Nigerians. Am J Ophthalmol 1972;74:451.

122.     Anderson DR. Perimetry: with and without automation. 2 ed. St. Louis: C.V. Mosby; 1987.

123.     Tomsak RL, Jergens PB. Benign recurrent transient monocular blindness: A possible variant of acephalgia migraine. Headache 1987;27:66-9.

124.     Kline LB, Kelley CL. Ocular migraine in a patient with cluster headache. Headache 1980;20:253-7.

125.     Gronvall A. On changes in the fundus oculi and persisting injuries to the eye in migraine. Acta Ophthalmol 1938;16:602.

126.     Cassen JH, Tomsak RL, DeLuise VP. Mixed arteriovenous occlusive disease of the fundus. J Clin Neuro-ophthalmol 1985;5:164-8.

127.     Wolter JR, Burchfield WJ. Ocular migraine in a young man resulting in unilateral transient blindness and retinal edema. J Pediatr Ophthalmol 1971;8:173.

128.     Burger SK, Saul RF, Selhorst JB, Thurston SE. Transient monocular blindness caused by vasospasm. N Engl J Med 1991;325:870-3.

129.     Graveson GS. Retinal arterial occlusion in migraine. Br Med J 1949;2:838.

130.     Krapin D. Occlusion of the central retinal artery in migraine. N Engl J Med 1964;270:359.

131.     Dalessio DJ. Wolff's Headache and Other Head Pain. 4 ed. New York: Oxford University Press; 1980.

132.     Hupp SL, Kline LB, Corbett JJ. Visual disturbance of migraine. Surv Ophthalmol 1989;33:221-36.

133.     Newman NJ, Lessell S, Brandt M. Bilateral central retinal artery occlusions, disk drusen, and migraine. Am J Ophthalmol 1989;107:236-40.

134.     Corbett JJ. Neuro-ophthalmic complications of migraine and cluster headaches. In: Smith CH, Beck RW, eds. Neurologic Clinics Symposium on Neuro-Ophthalmology. Philadelphia: WB Sanders; 1983:973-95.

135.     Coppeto JR, Monteiro MLR, Sciarra R. Giant cell arteritis with bilateral uveitic glaucoma. Ann Ophthalmol 1985;17:299-302.

136.     Lewis RA, Vijayan N, Watson C, Keltner J, Johnson CA. Visual field loss in migraine. Ophthalmol 1989;96:321-6.

137.     Carroll D. Retinal migraine. Headache 1970;10:9.

138.     Dirr LY, Janton FJ, Troost BT. Non-benign amaurosis fugax in a medical student. Neurology 1990;40:349.

139.     McDonald WI, Sanders MD. Migraine complicated by ischemic papillopathy. Lancet 1971;2:521.

140.     Laties AM. Central retinal artery innervation:  Absence of adrenergic innervation to the intraocular branches. Arch Ophthalmol 1967;77:405.

141.     Coppeto JR, Lessell S, Sciarra R, et.al. Vascular retinopathy in migraine. Neurology 1995.

142.     Larsen BH, Sorensen PS, Marquardsen J. Transient ischaemic attacks in young patients, a thromboembolic or migranous minifestation? A ten year follow up of 46 patients. J Neurol Neurosurg Psychiatr 1990;53:1029-33.

143.     Brown GC, Margargal LE, Shields JA, Goldberg RE, Walsh PN. Retinal arterial obstruction in children and young adults. Ophthalmology 1981;88:18-25.

144.     Kupersmith MJ, Hass WK, Chase NE. Isoproterenol treatment of visual symptoms in migraine. Stroke 1979;10:299-305.

145.     Kuhn WF, Kuhn SC, Daylida L. Basilar migraine. Eur J Emerg Med 1997;4:33-8.

146.     Panayiotopoulos CP. Basilar migraine. Neurology 1991;41:1707.

147.     Bickerstaff ER. Basilar artery migraine. Lancet 1961;1:15.

148.     Bickerstaff ER. Impairment of consciousness in migraine. Lancet 1961;2:1057.

149.     Lees F, Watkins SM. Loss of consciousness in migraine. Lancet 1963(2):647.

150.     Basser LS. The relation of migraine and epilepsy. Brain 1969;92:285.

151.     Bickerstaff ER. The basilar artery and the migraine-epilepsy syndrome. Proc R Soc Med 1962;55:167.

152.     Guest IA, Woolf AL. Fatal infarction of the brain in migraine. Br Med J 1964;1:225.

153.     Swanson JW, Vick NA. Basilar artery migraine, 12 patients, with an attack recorded electroencephalographically. Neurology 1978;28:782-6.

154.     Lance JW. The Mechanisms and Managment of Headache. London: Butterworth; 1969.